Overweight Clinical Trial
Official title:
BodyPump and Personal Training - Changes in Muscle Strength and Body Composition
| Verified date | November 2013 |
| Source | Norwegian School of Sport Sciences |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Norway: Regional Ethics Commitee |
| Study type | Interventional |
This study is a four armed randomized controlled trial (RCT) where the main purpose is to
investigate the effect on muscle strength and changes in body composition in overweight (BMI
˂ 25) "not regularly exercising" women aged 18-65, after 12 weeks of Body Pump (BP),
compared with an inactive control group. The study will also measure energy expenditure
during one session of BP. At the same time, the project will investigate the effect on
muscle strength and changes in body composition in group training with, respective without,
a personal trainer (PT).
H0: There`s no different between the groups after 12 weeks of Body Pump and traditional
strength training with and without a personal trainer on muscle strength and muscle mass in
adult overweight females.
H1: There is a different between the groups after 12 weeks of Body Pump and traditional
strength training with and without a personal trainer on muscle strength and muscle mass in
adult overweight females.
| Status | Completed |
| Enrollment | 144 |
| Est. completion date | April 2013 |
| Est. primary completion date | April 2013 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | 18 Years to 65 Years |
| Eligibility |
Inclusion criteria: - Women between 18 and 65 with BMI = 25.0 - Inactive the past six months; not been regularly physically active more than one hour each 14th.day - Able to transport themselves to training and testing - Able to understand Norwegian language written and oral - Healthy in the sense that they can conduct training and testing Exclusion criteria: - Diseases or injuries being contraindicated for participation - Scheduled extended vacation or absence from training during the intervention period prior to enrollment (>2 weeks) - Pregnant - Obesity surgery - Psycological diseases |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| Norway | Norwegian School of Sports Sciences | Oslo |
| Lead Sponsor | Collaborator |
|---|---|
| Norwegian School of Sport Sciences |
Norway,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Questionnaire | A questionnaire is included regarding different health perspectives, like subjective experiences from physical activities, motivation for exercise, attitudes toward physical activity and prevalence of musculoskeletal disorders. | 12 weeks | Yes |
| Primary | Muscle strength | One repetition maximum (1RM) test and submaximal strength tests (60 % load of 1RM) in squats (lower body) and bench press (upper body): Implementation: After warming-up, which consists of three series of gradually increasing load (40-75-85% of predicted 1RM) and reduction of repetitions (12-7-3), the subjects conduct the first attempt with a load around 5% below the expected 1RM. As approved trials increases the demand of 2-5%, until the subject fails. Resting periods between attempts are 3 to 5 minutes. The coefficient of variation is <5.4% in all the 1RM tests (Paulsen et al 2003). Submaximal tests are done after 1RM, based on the results from 1RM. The testing will be conducted by masterstudents included in the project, as well as an external personal trainer who takes care of spotting during squat. |
12 weeks | Yes |
| Secondary | Body composition | Changes in body composition will be measured with Inbody. Inbody separates adipose tissue and bonemass from other tissues in the body, leaving "lean body mass"(LBM). Any changes in LBM will primarily be due to changes in muscle mass. | 12 weeks | Yes |
| Secondary | Blood-lipids, blood-sugar and cholesterol | Capillary blood samples of the subjects is taken in fasting state, and will be used to analyze blood count (cholesterol (HDL, LDL), triglycerides, and glucose). | 12 weeks | Yes |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
| Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
| Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
| Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
| Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
| Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
| Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
| Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
| Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
| Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
| Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
| Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
| Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
| Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
| Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
| Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
| Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
| Completed |
NCT02899390 -
Diabetes Prevention Program in Adults of the Yaqui Tribe of Hermosillo, Sonora at Risk of Diabetes
|
N/A | |
| Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 |